Biologics

Former US President Donald Trump’s announcement of a 100% tariff on branded and patented pharmaceutical drugs has rattled India’s pharmaceutical sector. Effective 1st October 2025, this policy takes direct aim at biologics and complex generics—two of the fastest-growing segments for Indian manufacturers. India supplies nearly half the world’s generic medicines and leads global vaccine production, […]